Investment Strategy

China Outlook: Can China make it in 2025?

Nov 25, 2024

Author: Asia Investment Strategy Team
 

Two concurrent developments are impacting China in opposite ways. A policy shift is underway in Beijing that is driving fiscal support to the economy in an effort to stem the downturn and prevent deflation. From the other direction, a newly elected President Trump has vowed to dramatically increase tariffs on China and engage in a new trade war. In this note, we assess the potential paths of both developments and how their intersection could impact China’s outlook for 2025. 


The recent National People’s Congress (NPC) Standing Committee meeting announced a comprehensive debt restructuring plan that we think could have a modestly positive impact on growth. The Committee’s forward guidance for 2025 was also pretty consistent, reiterating that there is room for more fiscal expansion. Our expectation is for more policies to stabilize the property market, increase investment, and perhaps some measures to boost consumption. 

A comprehensive debt restructuring plan was put forward to resolve RMB 14.3tn of local government hidden debt. The plan consists of a RMB 6tn one-off resolution, RMB 4tn to be accounted for by future-year budgets, and a RMB 2tn deferred payment – with only RMB 2.3tn left for local governments themselves to resolve. The headline amount (RMB 14.3tn) is at the top end of market expectations, signaling a serious effort to resolve the debt issue.

A COMPREHENSIVE DEBT RESTRUCTURING PLAN HAS BEEN PUT FORWARD TO RESOLVE LOCAL GOVERNMENT HIDDEN DEBT

Local governments hidden debt, RMB trillions

Source: Bloomberg Finance L.P., J.P. Morgan Private Bank. Data as of November 2024. 
The chart shows local governments hidden debt totaled RMB 14.3 trillion, and a comprehensive debt restructuring plan has been put forward to resolve this. The plan consists of a RMB 6 trillion one-off increase in debt limit, RMB 4 trillion to be accounted for by 2024-2028 budgets, and a RMB 2 trillion payment deferred to post 2029, with only RMB 2.3 trillion left for local governments themselves to resolve.

Some investors have asked whether a debt restructuring means anything more than a large series of accounting changes. The reality is that not all debt is created equal. Off balance sheet debt is like private sector debt – it needs to be repaid fully at a point. Sovereign debt, on the other hand, is almost always refinanced. The duration extension and interest cost savings are additional benefits. Local governments were previously struggling to repay maturing debt, leading to salary cuts for civil servants, deferred payments for corporate suppliers and draconian tax collection measures. These were a significant drag on business sentiment. The restructuring takes this problem off the table. Local government bond issuance quotas will likely see a further increase as part of the upcoming 2025 budget, which means the green-lighting of more investment spending. The debt restructuring is the first step to reverse deflation, and to allow local governments to play a bigger role in counter-cyclical fiscal policies.      

As we wrote in earlier reports, since September, China’s policy focus has shifted back to the economy with the goal of ending deflation and turning around economic sentiment. The message from the NPC is still consistent with this direction. There is contention as to why the MoF couldn’t provide further details on the 2025 fiscal plan beyond the broad direction. In short, we don’t know. But given that the guidance hasn’t changed, we don’t view the lack of details as a dealbreaker. Our expectation is that policymakers will likely follow through on the announced state bank recapitalization plan and raise local government debt quotas further to support the housing market. The latter could see quotas being raised to around RMB 5tn for 2025. The official budget deficit will likely expand to around 4%, with expanded urbanization investments and targeted consumption support. There are opportunities for further policies during the year if and when tariffs go up. While tariffs are likely, the major uncertainty is over the magnitude of the growth challenges posed by tariffs, and the full policy response may only follow the specific tariff announcements.

A 60% TARIFF WOULD BE A SUBSTANTIAL INCREASE FROM CURRENT LEVELS

Average tariff rate, %

Source: Peterson Institute of International Economics, Bloomberg Finance L.P. Data as of November 2024. 
The chart shows U.S. average tariff rate against China exports and China average tariff rate against U.S. exports from 2018 to 2024, in percentage terms. U.S. average tariff rate against China exports increased from 3.10% in January 2018 to 21.0% in September 2019. It remained constant at 19.3% since February 2020 after falling from a peak of 21.0% Similarly, China average tariff rate against U.S. exports rose from 8% in January 2018 to 21.8% in February 2020 and remained steady since then at around 21.3%.


The known unknowns

As Trump builds out his cabinet and coterie of advisers, investors are turning their attention to the prospect of tariffs and a “Trade War 2.0”. There are currently a wide range of estimates on the impact of tariffs and the growth outlook. This highlights both the fluidity and the uncertainty of the situation especially around the magnitude, timing and format of the tariffs -- Will they go to 30% or 60%? Will that happen in 2025 or 2026? Will it be in phases or in one go, and do they start with certain categories of goods? Will there be tariffs on other economies?

Analysts are also split on the degree of total impact on GDP growth, for a few reasons. One is the global trade environment. During the first trade war, despite Chinese exports to the U.S. falling, they rose elsewhere, keeping overall Chinese exports relatively unimpacted (see chart below). The U.S. is only 15% of China’s overall exports, making the remaining 85% important for determining the trade outlook. Second, how much impact will there be on business and household sentiment? This is partly a function of policy calibration – will policymakers act to prevent a de-anchoring of business expectations or will a delay cause weak sentiment to become entrenched? Third, what will policymakers do to offset the tariff impact – and by how much? Lastly, the actual implementation and path of retaliation creates a slew of unknowns – for example: how much could currency depreciation offset the tariff rate; will there be retaliation and escalation; how much will be trans-shipped through other jurisdictions; and will tariffs be applied broadly to prevent transshipments?

CHINA’S OVERALL EXPORTS HAVE REMAINED STEADY EVEN AS EXPORTS TO THE U.S. HAVE FALLEN – A RESULT OF TRANSSHIPMENTS

China exports, USD billions

Source: China General Administration of Customs, Haver Analytics. Data as of October 2024. 
The chart shows China’s overall exports (represented by the left axis) and China’s exports to the U.S. (represented by the right axis) from 2016 to 2024, in USD billions. China’s overall exports have moved closely in line with exports to the U.S. from 2016 to 2022. China’s overall exports have increased from 177 billions in January 2016 to 308 billions in May 2022, despite a dip in 2020. Similarly, China’s exports to the U.S. rose from 33 billions in January 2016 to 53 billions in May 2022. However, there was a sharp decline in China’s exports to the U.S., from 53 billions in May 2022 to 38 billions in October 2022, and has only increased slightly to 44 billions in September 2024, despite some fluctuations during that period. On the other hand, China’s overall exports remained steady at around 300 billions during the same period from May 2022 to September 2024.

The known knowns

Despite the many unknowns, a certainty is that a trade war with the U.S. would have a considerably negative impact on China’s economy, for a few reasons. First, except for a spike during Covid, China is currently more reliant on exports to drive its economy than at any point since the 2000s. Given the weakness in domestic consumption and investment, exports have become a key driver of growth. This is evident in both GDP and trade data, where a surging gap between imports and exports highlights how extreme this imbalance has become. Second, despite the U.S. only accounting for 15% of China’s exports, it is still the single largest trading partner and over 3x larger than the next largest export destination. Exports to the U.S. account for approximately 4% of China’s GDP. If the U.S. dramatically reduces demand for China-produced goods, and cuts off paths for transshipment, it would undeniably have a meaningful impact. A key reason Chinese exports stayed resilient during the first trade war was that transshipments were occurring through other countries, with the U.S. as a final destination, and not because rest-of-world demand dramatically increased and offset the U.S. For this reason, the potential for transshipment will be a key factor to watch.

EXPORTS HAVE BECOME A KEY DRIVER OF GROWTH GIVEN THE WEAKNESS IN DOMESTIC CONSUMPTION AND INVESTMENT

Share of China’s GDP growth, quarterly %

Source: China National Bureau of Statistics, Haver Analytics. Data as of September 2024. 
The chart shows the share of China’s GDP growth from 2015 to 2024 on a quarterly basis, by consumption, investment and net exports. Historically, consumption has been a key driver of growth, ranging around 60-70% during the period of 2015 to 2022. Investment is the 2nd key driver of GDP growth, at around 40% during the period of 2015 to 2020. There was a spike in the share of GDP growth for investment in June 2020 while consumption fell from approximately 50% to -68.4% in June 2020. From 2020 to 2022, investment as a share of China’s GDP growth has been gradually declining from 40.5% in September 2020 to 16.9% in March 2022. Lastly, net exports’ share of China’s GDP growth was mostly negative from 2015 to 2019. From 2019 to 2022, it turned positive and was fluctuating within the range of 10-20% before spiking to 239% in June 2022. After the pandemic in early 2022, net exports fell from a peak of 239% in June 2022 to -43.3% in December 2022. From December 2022 to September 2024, it has increased from -43.3% to 42.9%. In contrast, consumption has dipped to 29.3% in September 2024 after reaching a peak of 94.4% in September 2023. Similarly, investment as a share of GDP growth has fallen and remained subdued after reaching a peak of 130.5% in December 2022. it declined to 27.8% as of September 2024.

THE SURGING GAP BETWEEN EXPORTS AND IMPORTS HIGHLIGHTS A WIDENING TRADE IMBALANCE

China export/import volumes, indexed to 2010 = 100

Source: China General Administration of Customs, Haver Analytics. Data as of September 2024. 
The chart shows China’s export and import volumes from 2010 to 2024, with 2010 set as the base year (100). Exports volume has increased from 92 in January 2010 to 168 in July 2020 and imports volume has increased from 89 in January 2010 to 165 in July 2020. Since July 2020, both exports and imports volumes have continued their uptrend, but exports volume has been increasing at a faster pace than imports volume, resulting in a widening trade balance. Exports volume grew from 168 in July 2020 to 214 in September 2024. While imports volume has increased from 165 in July 2020 to 161 in September 2024, it has lagged exports volume.

To illustrate the impact, let’s start with the assumption that the tariff rate goes up to 60% on all goods in the first half of 2025. Based on the experience of the last trade war, this could significantly reduce bilateral trade between the U.S. and China. We estimate there will likely be a negative shock to economic growth, through exports, investment, employment, and broader confidence. Putting aside the possibility for transshipment for now, we estimate a 60% tariff could lead to a 1-1.5ppt drag on economic growth over a twelve-month period. 

How do we get to this number? Every 1ppt increase in the tariff rate roughly translates into a -0.9ppt drag on China’s exports to the United States. So assuming an increase to 60%, that’s around a 40ppt drag on exports to the U.S. This should translate into a 6ppt hit to overall exports, and about 1ppt hit to real GDP growth, purely through the trade channel. Because the export sector is a big employer and source of investment, there are knock-on effects throughout the economy.

We think the impact could be near the lower end of the range if transshipments are strong, but at the high end or possibly above the range if transshipment routes are shut off. Transshipments offset most of the tariff impact in the last trade war. Since then, overall exports have grown despite a slowdown in bilateral trade with the United States. We think it’s prudent to bake in some degree of impact to sentiment, as uncertainty is likely to be high. That said, our assumption is that policymakers will likely act to arrest a meaningful decline in business confidence. We also assume they will likely launch more stimulus to offset the growth impact. All policy tools are on the table, but the exact split between fiscal, monetary and FX will likely depend on the situation at that point in time. For this reason, our overall growth outlook is not as bearish as some of the estimates on the street.

Another question is whether the incoming U.S. administration will follow through with tariffs or if they will be used as a negotiating tool to achieve a deal. This is currently an open debate, but market pricing (and sentiment across Asia) appears to lean towards a belief that tariffs are merely a negotiating tool, given that many tariff-sensitive assets have yet to fully “price in” the potential impact. While it’s impossible to know exactly what the next administration will do, it can be helpful to analyze their goals and constraints, and walk back the policy options that can achieve those goals within their constraints.

What are the U.S. intentions around trade policy? What are they trying to achieve? This is important to analyze with regards to the U.S.-China trade relationship as it could point to very different outcomes. If the goal is to reduce the trade deficit with China, redirect trade to other countries, or simply provide less foreign currency revenue to China, then tariffs to block trade would be the desired tool. If the goal is to further open China’s markets to U.S. firms, have China buy more U.S. exports and become a larger market for U.S. producers, or to drive structural reforms, then using tariffs as a negotiating tool could help achieve these outcomes. In short – if the goal is decoupling, then tariffs could be used to block trade. If the goal is further integration of the U.S. and Chinese economies through a deal, then tariffs could be used to achieve some grand bargain.

Most indications from Washington are that a deal is not achievable, nor politically palatable. There is a belief in Washington that the structural reforms proposed in the first trade deal (but ultimately rejected)  are unachievable, and a further deepening of the U.S.-China relationship – thereby making U.S. producers even more reliant on Chinese demand – is not the desired outcome. While trying to understand the path of future policy, investors have to ask if U.S. policymakers want a deal that deepens the economic relationship and makes the U.S. more reliant on China, or do they simply want to buy less goods from China?

If the path is tariffs and no deal, would the U.S. economy be too constrained by inflation to raise tariffs? It is important to understand what constraints could limit the use of tariffs as trade policy. Starting with inflation: core goods inflation accounts for 20% of core PCE, and 35% of core goods are imported. In the scenario where tariffs are increased on imports from China, the headline tariff rate could increase by around 35-40% points. Given that imports from China account for 13.5% of all imports, in a rough estimation this would all translate to 33bps upside for core PCE inflation (20% x 35% x 13.5% x 35pp = 33bps) – not zero, but not a meaningful increase. Using elasticities from the first trade war, the estimated increase would be 40bps. It’s important to make a distinction between tariffs on just China and a blanket 10-20% tariffs on all imports. By the same calculation, a 10% tariff on all core goods could result in an initial upside of 70bps for core inflation (20% x 35% x 10pp). Ten percent on everything would be much more impactful than tariffs just on China, from an inflation perspective.

It’s also worth noting that the final effect on inflation will likely depend on a number of factors, and some of these can play a bigger role in influencing inflation than just the direct effects of tariffs. For example, over the 2018-19 trade war period, core goods PCE inflation actually remained in negative territory and in a range between -0.9% and -0.1%.

The other factors to watch are:

1) How much of an offset could there be from USD appreciation? In 2018-19, CNH depreciated by 11.6%, which offset 65% of the increase in the effective tariff rate.

2) Whether the U.S. will be able to divert and secure alternative sources to replace imports from China and at what price. Much of the textiles, apparel, and toys can be sourced elsewhere. Some electronics and other goods are more challenging.

3) Global goods demand. It’s important to focus on the growth implications and not just the inflationary implications. The rise of trade tensions in 2018-19 slowed global demand as financial conditions tightened and corporate confidence suffered. The weaker demand outlook led to lower global goods prices and even weighed on commodity and intermediate product prices.

In other words, there are many factors that could influence the final inflationary impact that makes modeling it extremely difficult.

CHINA’S EXCESS SUPPLY IS EVIDENCED IN DEFLATIONARY EXPORT PRICES, THIS CAN HELP BRING DOWN INFLATION IN THE U.S.

U.S. import prices, year-over-year %

Source: EPFR, Exante, J.P. Morgan Private Bank. Data as of October 2024.
The chart shows U.S. import prices (year-over-year percentage changes) from 2014 to 2024, broken down by key regions: China, Japan, Mexico and Europe. U.S import prices have moved largely in line for the 4 regions from 2014 to 2022. However, the chart highlights China’s deflationary export prices, showing a significant decline into negative territory in recent years, shown in prices of U.S. imports from China. Its year-over-year change has been on a sharp downtrend since October 2022 and fell into negative territory in August 2023. Since then, year-over-year change of U.S. import prices for China continued to fall from -0.19% in August 2023 to -2.52% in October 2024, highlighting its deflationary pressures. This is in contrast with the 3 other regions, where year-over-year growth of U.S. import prices has largely stayed around zero or positive territory in recent years.

Looking first at trade, it’s important to understand just how unbalanced the U.S.-China trade relationship is – it is the U.S.’s largest deficit and China’s largest surplus by a large margin. When counting both goods and services, U.S. trade is fairly balanced, with the major exception of China. When looking at it from China’s perspective, China’s trade is fairly balanced, with the large exception of the U.S. With such a large surplus, it limits China’s ability to retaliate through the trade channel. Put another way, China’s exports to the U.S. are about 3-4% of China’s GDP, while U.S. exports to China are 0.5% of GDP.

THE TRADE RELATIONSHIP BETWEEN THE U.S. AND CHINA IS AMONG THE MOST IMBALANCED IN THE WORLD

China value-added trade balance, USD millions

Source: OECD, Haver Analytics. Data as of December 2020. 
The bar chart shows China’s value-added trade balance, in USD millions with EU28, Vietnam, Thailand, Taiwan, Brazil, U.S., U.K., South Korea, Japan, Germany, France and Australia in 2020. Value added trade balance considers the value added by each country in the production of goods and services that are consumed worldwide. China runs a trade deficit with 9 countries/regions in 2020, namely the EU28 (USD 13.9bn), Vietnam (USD 9.2bn), Thailand (USD 579 mn), Taiwan (USD 64.7bn), Brazil (USD 31.4bn), South Korea (USD 47.4bn), Germany (USD 25.9bn), France (USD 2.8bn) and Australia (USD 58.4 bn). China runs a valued-added trade surplus with 3 countries, namely U.S. (USD 235bn), UK (USD 25.8bn) and Japan (USD 18.3bn). Amongst the 3 countries that China runs a trade surplus with, it has the largest value-added trade surplus against the U.S..

Here it’s a mixed bag, and it’s the one area where retaliation could potentially limit the scope of tariffs. On the one hand, U.S. corporate exposure to China is quite limited. On the whole, U.S. multinationals derive about 1% of profits from China, however when looking at the S&P 500, the number increases to about 7.5%. At the macro level, any retaliation through market access by limiting American corporate sales in China is unlikely to have an impact, but at the listed level it could have an impact and feed through to the market. If stock market downside is something policymakers wish to avoid then any retaliation against large listed corporates with significant business exposure to China could potentially constrain the application of tariffs. This doesn’t come without costs to China, but this is the key area to watch in terms of equity market impact.

A Trump presidency presents asymmetric risks to the Chinese yuan. Potential trade disputes could lead to a depreciation in the yuan's fair value, driven by a deterioration in the current account and adverse effects on capital flows. Conversely, the U.S. dollar may experience further strengthening over the next 6 to 12 months, supported by U.S. economic growth and interest rate exceptionalism.

Reflecting on historical precedents, during the 2018-2020 trade war between the U.S. and China, the offshore yuan (CNH) weakened against the dollar by as much as 15%. This depreciation coincided with an approximate 15% increase in effective tariff rates imposed by the U.S. on Chinese goods during that period, with a highly correlated path. This correlation may be attributed to the PBOC’s stance on foreign exchange, as currency devaluation could serve to mitigate the impact of tariffs. Given the fact that the yuan is heavily managed by the central bank, the PBOC's tolerance for currency weakness is critical to its outlook. Notably, the yuan’s current exchange rate against a basket of currencies remains significantly stronger than the levels observed during 2018-2020.

THERE WAS A HIGH CORRELATION BETWEEN CNH EXCHANGE RATES AND EFFECTIVE TARIFF RATES DURING THE 2018-20 TRADE WAR

Source: Bloomberg Finance L.P., J.P. Morgan Private Bank. Data as November 2024. 
The line chart plots the effective tariff rate on China exports to U.S. on the right axis and USDCNH on the left axis from January 2018 to May 2020. The effective tariff rate on China exports to U.S. started at 3.1% in January 2018 and increased slightly to 3.2% in March 2018. USDCNH started at 6.52 in January 2018 but fell slightly to 6.3 in February 2018. From February 2018 to March 2018, USDCNH was largely rangebound, fluctuating around ~6.3. From March 2018 to September 2018, the effective tariff rate on China exports to US increased from 3.2% to 12%, with resulted in a sharp depreciation of CNH as USDCNH increased from 6.3 in March 2018 to 6.8 in September 2018. From September 2018 to May 2019, the effective tariff rate on China exports to US remained constant at 12%. Even though there was a modest appreciation of CNH against USD, with USDCNH falling slightly from 6.8 in September 2018 to 6.7 in April 2019., there was no sharp increase or decline in USDCNH. In May 2019, there was a hike in U.S. tariffs on China exports, as the effective tariff rate on China exports to US rose from 12% in May 2019 to 17.3% in June 2019. USD appreciated against the CNH leading up to the tariff hike, with USDCNH increasing from 6.7 in April 2019 to 6.9 in May 2019. Following the rate hike, USDCNH stayed flat at ~6.8 from June 2019 to July 2019, at the same time effective tariff rate on China exports to US remained constant at 17.3%. It was only until August 2019 that we saw a sharp depreciation of CNH against USD, as USDCNH increased from 6.8 in July 2019 to 7.2 in September 2019. CNH started depreciating against USD in early August 2019, leading up to the tariff rate hike in September 2019 which saw effective tariff rate on China exports to US increased from 17.3% to 21%. From September 2019 to May 2020, the effective tariff rate on China exports to US fell slightly from 21% to 19.3%, despite some fluctuations in between. During the same period, USDCNH, fell from 7.2 in September 2019 to 7.1 as of June 2020, suggesting a slight appreciation of CNH. Overall, an increase in the effective rate on China exports to US negatively impacts the CNH.

WHILE THE YUAN HAS A WEAKER STARTING POINT AGAINST THE USD, THE TRADE WEIGHTED RMB IS STILL MEANINGFULLY ABOVE 2018-20 LEVELS

CFETS RMB Index

Source: Bloomberg Finance L.P., J.P. Morgan Private Bank. Data as November 2024. 
The chart shows CFETs RMB Index which measures the value of Chinese yuan (RMB) relative to a basket of currencies. The index is managed by the China Foreign Exchange Trade System (CFETs), which is a subsidiary of the People’s Bank of China (PBoC). The purpose of the CFETs RMB is to provide a more comprehensive view of the yuan’s value against a broader range of currencies, rather than just the U.S. dollar. The CFETs RMB Index started at 95 in 2017 and increased to 97.85 in June 2018. From June 2018 to January 2020, which is the period of the U.S. China Trade War, the CFETs RMB Index declined from 97.85 to 93 in January 2020, it then increased steadily to a peak of 106.8 in March 2022. From March 2022 to July 2023, the CFETs RMB Index fell from 106.8 in March 2022 to 95.9 in July 2023. It then increased to 100.7 in April 2024 but has dipped to 97.8 as of September 2024. Despite rising from a trough of 97.8 in September 2024 to 100 in November 2024, the index is still above 2018-20 levels.

As previously mentioned, further policy easing will likely be a  response to increased U.S. tariffs or more aggressive anti-China policies. While such measures could help improve risk sentiment and cushion economic growth in China, we anticipate mixed implications for the yuan, as additional monetary easing would increase currency supply and exacerbate the carry disadvantage.

Therefore, we anticipate a weaker CNH outlook with heightened volatility. Geopolitical risk premiums are expected to dominate over the next 6 to 12 months, with considerable uncertainty surrounding the levels and scope of tariffs that may be implemented. We encourage investors with long CNH exposure to consider hedging strategies. Additionally, the yuan could be utilized as a funding currency to capitalize on opportunities in other markets.

So far, Chinese equities have broadly responded as expected. Tariff concerns and a stronger dollar are headwinds for offshore China, and broader Asia Emerging Markets. We see limited upside for these markets. A more forceful-than-expected fiscal response from Chinese authorities remains a possibility to offset potential economic headwinds from a renewed trade war, but we await more clarity and details before factoring this in. Overall, this backdrop is more supportive for onshore China relative to offshore China, but we retain a neutral view on both markets in 2025 for now. We see trading the range-bound market and utilizing structures as preferred ways to participate.

All market and economic data as of November 25, 2024 and sourced from Bloomberg Finance L.P. and FactSet unless otherwise stated.

For illustrative purposes only. Estimates, forecasts and comparisons are as of the dates stated in the material.

There can be no assurance that any or all of these professionals will remain with the firm or that past performance or success of any such professional serves as an indicator of the portfolio’s success.

We believe the information contained in this material to be reliable but do not warrant its accuracy or completeness. Opinions, estimates, and investment strategies and views expressed in this document constitute our judgment based on current market conditions and are subject to change without notice.

This document may also have been made available in a different language, at the recipient’s request, and for convenience only. Notwithstanding the provision of a convenience copy, the recipient re-confirms that he/she/they are fully conversant and has full comprehension of the English language. In the event of any inconsistency between such English language original and the translation, including without limitation in relation to the construction, meaning or interpretation thereof, the English language original shall prevail.

This information is provided for informational purposes only. We believe the information contained in this video to be reliable; however we do not represent or warrant its accuracy, reliability or completeness, or accept any liability for any loss or damage arising out of the use of any information in this video. The views expressed herein are those of the speakers and may differ from those of other J.P. Morgan employees, and are subject to change without notice. Nothing in this video is intended to constitute a representation that any product or strategy is suitable for you. Nothing in this document shall be regarded as an offer, solicitation, recommendation or advice (whether financial, accounting, legal, tax or other) given by J.P. Morgan and/or its officers or employees to you. You should consult your independent professional advisors concerning accounting, legal or tax matters. Contact your J.P. Morgan team for additional information and guidance concerning your personal investment goals.

Indices are not investment products and may not be considered for investment.

We are not recommending the use of benchmarks as a tool for performance analysis purposes. The benchmarks used in this report are for your reference only.

For illustrative purposes only. This does not reflect the performance of any specific investment scenario and does not take into account various other factors which may impact actual performance.

Past performance is not a guarantee of future results.  It is not possible to invest directly in an index.

The information presented is not intended to be making value judgments on the preferred outcome of any government decision or political election.

All companies referenced are shown for illustrative purposes only, and are not intended as a recommendation or endorsement by J.P. Morgan in this context.

International investments may not be suitable for all investors. International investing involves a greater degree of risk and increased volatility. Changes in currency exchange rates and differences in accounting and taxation policies outside the U.S. can raise or lower returns. Some overseas markets may not be as politically and economically stable as the United States and other nations. Investments in international markets can be more volatile.​

Holders of foreign securities can be subject to foreign exchange risk, exchange-rate risk and currency risk, as exchange rates fluctuate between an investment’s foreign currency and the investment holder’s domestic currency. Conversely, it is possible to benefit from favorable foreign exchange fluctuations.

RISK CONSIDERATIONS 

  • Past performance is not indicative of future results. You may not invest directly in an index. 
  • The prices and rates of return are indicative as they may vary over time based on market conditions. 
  • Additional risk considerations exist for all strategies. 
  • The information provided herein is not intended as a recommendation of or an offer or solicitation to purchase or sell any investment product or service. 
  • Opinions expressed herein may differ from the opinions expressed by other areas of J.P. Morgan. This material should not be regarded as investment research or a J.P. Morgan investment research report.

Contact us to discuss how we can help you experience the full possibility of your wealth.

Please tell us about yourself, and our team will contact you. 

*Required Fields

Contact us to discuss how we can help you experience the full possibility of your wealth.

Please tell us about yourself, and our team will contact you. 

Enter your First Name

> or < are not allowed

Only 40 characters allowed

Enter your Last Name

> or < are not allowed

Only 40 characters allowed

Select your country of residence

Enter valid street address

> or < are not allowed

Only 150 characters allowed

Enter your city

> or < are not allowed

Only 35 characters allowed

Select your state

> or < are not allowed

Enter your ZIP code

Please enter a valid zipcode

> or < are not allowed

Only 10 characters allowed

Enter your postal code

Please enter a valid zipcode

> or < are not allowed

Only 10 characters allowed

Enter your country code

Enter your country code

> or < are not allowed

Enter your phone number

Phone number must consist of 10 numbers

Please enter a valid phone number

> or < are not allowed

Only 15 characters allowed

Enter your phone number

Please enter a valid phone number

> or < are not allowed

Only 15 characters allowed

Tell Us More About You

0/1000

Only 1000 characters allowed

> or < are not allowed

Checkbox is not selected

Your Recent History

Important Information

Key Risks

This material is for information purposes only, and may inform you of certain products and services offered by private banking businesses, part of JPMorgan Chase & Co. (“JPM”). Products and services described, as well as associated fees, charges and interest rates, are subject to change in accordance with the applicable account agreements and may differ among geographic locations. Not all products and services are offered at all locations. If you are a person with a disability and need additional support accessing this material, please contact your J.P. Morgan team or email us at accessibility.support@jpmorgan.com for assistance. Please read all Important Information.

GENERAL RISKS & CONSIDERATIONS

Any views, strategies or products discussed in this material may not be appropriate for all individuals and are subject to risks. Investors may get back less than they invested, and past performance is not a reliable indicator of future results. Asset allocation/diversification does not guarantee a profit or protect against loss. Nothing in this material should be relied upon in isolation for the purpose of making an investment decision. You are urged to consider carefully whether the services, products, asset classes (e.g., equities, fixed income, alternative investments, commodities, etc.) or strategies discussed are suitable to your needs. You must also consider the objectives, risks, charges and expenses associated with an investment service, product or strategy prior to making an investment decision. For this and more complete information, including discussion of your goals/situation, contact your J.P. Morgan team.

NON-RELIANCE

Certain information contained in this material is believed to be reliable; however, JPM does not represent or warrant its accuracy, reliability or completeness, or accept any liability for any loss or damage (whether direct or indirect) arising out of the use of all or any part of this material. No representation or warranty should be made with regard to any computations, graphs, tables, diagrams or commentary in this material, which are provided for illustration/ reference purposes only. The views, opinions, estimates and strategies expressed in this material constitute our judgment based on current market conditions and are subject to change without notice. JPM assumes no duty to update any information in this material in the event that such information changes. Views, opinions, estimates and strategies expressed herein may differ from those expressed by other areas of JPM, views expressed for other purposes or in other contexts, and this material should not be regarded as a research report. Any projected results and risks are based solely on hypothetical examples cited, and actual results and risks will vary depending on specific circumstances. Forward-looking statements should not be considered as guarantees or predictions of future events.

Nothing in this document shall be construed as giving rise to any duty of care owed to, or advisory relationship with, you or any third party. Nothing in this document shall be regarded as an offer, solicitation, recommendation or advice (whether financial, accounting, legal, tax or other) given by J.P. Morgan and/or its officers or employees, irrespective of whether or not such communication was given at your request. J.P. Morgan and its affiliates and employees do not provide tax, legal or accounting advice. You should consult your own tax, legal and accounting advisors before engaging in any financial transactions.

Your investments and potential conflicts of interest

Conflicts of interest will arise whenever JPMorgan Chase Bank, N.A. or any of its affiliates (together, “J.P. Morgan”) have an actual or perceived economic or other incentive in its management of our clients’ portfolios to act in a way that benefits J.P. Morgan. Conflicts will result, for example (to the extent the following activities are permitted in your account): (1) when J.P. Morgan invests in an investment product, such as a mutual fund, structured product, separately managed account or hedge fund issued or managed by JPMorgan Chase Bank, N.A. or an affiliate, such as J.P. Morgan Investment Management Inc.; (2) when a J.P. Morgan entity obtains services, including trade execution and trade clearing, from an affiliate; (3) when J.P. Morgan receives payment as a result of purchasing an investment product for a client’s account; or (4) when J.P. Morgan receives payment for providing services (including shareholder servicing, recordkeeping or custody) with respect to investment products purchased for a client’s portfolio. Other conflicts will result because of relationships that J.P. Morgan has with other clients or when J.P. Morgan acts for its own account.

Investment strategies are selected from both J.P. Morgan and third-party asset managers and are subject to a review process by our manager research teams. From this pool of strategies, our portfolio construction teams select those strategies we believe fit our asset allocation goals and forward-looking views in order to meet the portfolio's investment objective.

As a general matter, we prefer J.P. Morgan managed strategies. We expect the proportion of J.P. Morgan managed strategies will be high (in fact, up to 100 percent) in strategies such as, for example, cash and high-quality fixed income, subject to applicable law and any account-specific considerations.

While our internally managed strategies generally align well with our forward-looking views, and we are familiar with the investment processes as well as the risk and compliance philosophy of the firm, it is important to note that J.P. Morgan receives more overall fees when internally managed strategies are included. We offer the option of choosing to exclude J.P. Morgan managed strategies (other than cash and liquidity products) in certain portfolios.

The Six Circles Funds are U.S.-registered mutual funds managed by J.P. Morgan and sub-advised by third parties. Although considered internally managed strategies, JPMC does not retain a fee for fund management or other fund services.

Legal entity, brand & regulatory information

In the United States, bank deposit accounts and related services, such as checking, savings and bank lending, are offered by JPMorgan Chase Bank, N.A. Member FDIC.

JPMorgan Chase Bank, N.A. and its affiliates (collectively “JPMCB”) offer investment products, which may include bank-managed investment accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC (“JPMS”), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPM. Products not available in all states.

In Germany, this material is issued by J.P. Morgan SE, with its registered office at  Taunustor 1 (TaunusTurm), 60310 Frankfurt am Main, Germany, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB). In Luxembourg, this material is issued by J.P. Morgan SE – Luxembourg Branch, with registered office at European Bank and Business Centre, 6 route de Treves, L-2633, Senningerberg, Luxembourg, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Luxembourg Branch is also supervised by the Commission de Surveillance du    Secteur Financier (CSSF); registered under R.C.S Luxembourg B255938. In the United Kingdom, this material is issued by J.P. Morgan SE – London Branch, registered office at 25 Bank Street, Canary Wharf, London E14 5JP, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – London Branch is also supervised by the Financial Conduct Authority and Prudential Regulation Authority. In Spain, this material is distributed by J.P. Morgan SE, Sucursal en España, with registered office at Paseo de la Castellana, 31, 28046 Madrid, Spain, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE, Sucursal en España is also supervised by the Spanish Securities Market Commission (CNMV); registered with Bank of Spain as a branch of J.P. Morgan SE under code 1567. In Italy, this material is distributed by J.P. Morgan SE – Milan Branch, with its registered office at Via Cordusio, n.3, Milan 20123,  Italy, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Milan Branch is also supervised by Bank  of Italy and the Commissione Nazionale per le Società e la Borsa (CONSOB); registered with Bank of Italy as a branch of J.P. Morgan SE under code 8076; Milan Chamber of Commerce Registered Number: REA MI 2536325. In the Netherlands, this material is distributed by  J.P. Morgan SE – Amsterdam Branch, with registered office at World Trade Centre, Tower B, Strawinskylaan 1135, 1077 XX, Amsterdam, The Netherlands, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Amsterdam Branch is also supervised by De Nederlandsche Bank (DNB) and the Autoriteit Financiële Markten (AFM) in the Netherlands. Registered with the Kamer van Koophandel as a branch of J.P. Morgan SE under registration number 72610220. In Denmark, this material is distributed by J.P. Morgan SE – Copenhagen Branch, filial af J.P. Morgan SE, Tyskland, with registered office at Kalvebod Brygge 39-41, 1560 København V, Denmark, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Copenhagen Branch, filial af J.P. Morgan SE, Tyskland is also supervised by Finanstilsynet (Danish FSA) and is registered with Finanstilsynet as a branch of J.P. Morgan SE under code 29010. In Sweden, this material is distributed by J.P. Morgan SE – Stockholm Bankfilial, with registered office at Hamngatan 15, Stockholm, 11147, Sweden, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Stockholm Bankfilial is also supervised by Finansinspektionen (Swedish FSA); registered with Finansinspektionen as a branch of J.P. Morgan SE. In Belgium, this material is distributed by J.P. Morgan SE – Brussels Branch with registered office at 35 Boulevard du Régent, 1000, Brussels, Belgium, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB);  J.P. Morgan SE Brussels Branch is also supervised by the National Bank of Belgium (NBB) and the Financial Services and Markets Authority (FSMA) in Belgium; registered with the NBB under registration number 0715.622.844. In Greece, this material is distributed by J.P. Morgan SE – Athens Branch, with its registered office at 3 Haritos Street, Athens, 10675, Greece, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB); J.P. Morgan SE – Athens Branch is also supervised by Bank of Greece; registered with Bank of Greece as a branch of J.P. Morgan SE under code 124; Athens Chamber of Commerce Registered Number 158683760001; VAT Number 99676577. In France, this material is distributed by J.P. Morgan SE – Paris Branch, with its registered office at 14, Place Vendome 75001 Paris, France, authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB) under code 842 422 972; J.P. Morgan SE – Paris Branch is also supervised by the French banking authorities the Autorité de Contrôle Prudentiel et de Résolution (ACPR) and the Autorité des Marchés Financiers (AMF). In Switzerland, this material is distributed by J.P. Morgan (Suisse) SA, with registered address at rue du Rhône, 35, 1204, Geneva, Switzerland, which is authorised and supervised by the Swiss Financial Market Supervisory Authority (FINMA) as a bank and a securities dealer in Switzerland.

This communication is an advertisement for the purposes of the Markets in Financial Instruments Directive (MIFID II) and the Swiss Financial Services Act (FINSA). Investors should not subscribe for or purchase any financial instruments referred to in this advertisement except on the basis of information contained in any applicable legal documentation, which is or shall be made available in the relevant jurisdictions (as required).

In Hong Kong, this material is distributed by JPMCB, Hong Kong branch. JPMCB, Hong Kong branch is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission of Hong Kong. In Hong Kong, we will cease to use your personal data for our marketing purposes without charge if you so request. In Singapore, this material is distributed by JPMCB, Singapore branch. JPMCB, Singapore branch is regulated by the Monetary Authority of Singapore. Dealing and advisory services and discretionary investment management services are provided to you by JPMCB, Hong Kong/Singapore branch (as notified to you). Banking and custody services are provided to you by JPMCB Singapore Branch. The contents of this document have not been reviewed by any regulatory authority in Hong Kong, Singapore or any other jurisdictions. You are advised to exercise caution in relation to this document. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. For materials which constitute product advertisement under the Securities and Futures Act and the Financial Advisers Act, this advertisement has not been reviewed by the Monetary Authority of Singapore. JPMorgan Chase Bank, N.A., a national banking association chartered under the laws of the United States, and as a body corporate, its shareholder’s liability is limited.

With respect to countries in Latin America, the distribution of this material may be restricted in certain jurisdictions. We may offer and/or sell to you securities or other financial instruments which may not be registered under, and are not the subject of a public offering under, the securities or other financial regulatory laws of your home country. Such securities or instruments are offered and/or sold to you on a private basis only. Any communication by us to you regarding such securities or instruments, including without limitation the delivery of a prospectus, term sheet or other offering document, is not intended by us as an offer to sell or a solicitation of an offer to buy any securities or instruments in any jurisdiction in which such an offer or a solicitation is unlawful. Furthermore, such securities or instruments may be subject to certain regulatory and/or contractual restrictions on subsequent transfer by you, and you are solely responsible for ascertaining and complying with such restrictions. To the extent this content makes reference to a fund, the Fund may not be publicly offered in any Latin American country, without previous registration of such fund´s securities in compliance with the laws of the corresponding jurisdiction. 

References to “J.P. Morgan” are to JPM, its subsidiaries and affiliates worldwide. “J.P. Morgan Private Bank” is the brand name for the private banking business conducted by JPM. This material is intended for your personal use and should not be circulated to or used by any other person, or duplicated for non-personal use, without our permission. If you have any questions or no longer wish to receive these communications, please contact your J.P. Morgan team.

JPMorgan Chase Bank, N.A. (JPMCBNA) (ABN 43 074 112 011/AFS Licence No: 238367) is regulated by the Australian Securities and Investment Commission and the Australian Prudential Regulation Authority. Material provided by JPMCBNA in Australia is to “wholesale clients” only. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Corporations Act 2001 (Cth). Please inform us if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.

JPMS is a registered foreign company (overseas) (ARBN 109293610) incorporated in Delaware, U.S.A. Under Australian financial services licensing requirements, carrying on a financial services business in Australia requires a financial service provider, such as J.P. Morgan Securities LLC (JPMS), to hold an Australian Financial Services Licence (AFSL), unless an exemption applies. JPMS is exempt from the requirement to hold an AFSL under the Corporations Act 2001 (Cth) (Act) in respect of financial services it provides to you, and is regulated by the SEC, FINRA and CFTC under US laws, which differ from Australian laws. Material provided by JPMS in Australia is to “wholesale clients” only. The information provided in this material is not intended to be, and must not be, distributed or passed on, directly or indirectly, to any other class of persons in Australia. For the purposes of this paragraph the term “wholesale client” has the meaning given in section 761G of the Act. Please inform us immediately if you are not a Wholesale Client now or if you cease to be a Wholesale Client at any time in the future.

This material has not been prepared specifically for Australian investors. It:

  • may contain references to dollar amounts which are not Australian dollars;
  • may contain financial information which is not prepared in accordance with Australian law or practices;
  • may not address risks associated with investment in foreign currency denominated investments; and
  • does not address Australian tax issues.

© 2024 JPMorgan Chase & Co. All rights reserved.

LEARN MORE About Our Firm and Investment Professionals Through FINRA BrokerCheck

 

To learn more about J.P. Morgan’s investment business, including our accounts, products and services, as well as our relationship with you, please review our J.P. Morgan Securities LLC Form CRS and Guide to Investment Services and Brokerage Products

 

JPMorgan Chase Bank, N.A. and its affiliates (collectively "JPMCB") offer investment products, which may include bank-managed accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC ("JPMS"), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPMorgan Chase & Co. Products not available in all states.

 

Please read the Legal Disclaimer for key important J.P. Morgan Private Bank information in conjunction with these pages.

INVESTMENT AND INSURANCE PRODUCTS ARE: • NOT FDIC INSURED • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY • NOT A DEPOSIT OR OTHER OBLIGATION OF, OR GUARANTEED BY, JPMORGAN CHASE BANK, N.A. OR ANY OF ITS AFFILIATES • SUBJECT TO INVESTMENT RISKS, INCLUDING POSSIBLE LOSS OF THE PRINCIPAL AMOUNT INVESTED

Bank deposit products, such as checking, savings and bank lending and related services are offered by JPMorgan Chase Bank, N.A. Member FDIC.

Not a commitment to lend. All extensions of credit are subject to credit approval.

Equal Housing Lender Icon